Symbol="ARQT"
AssetType="Common Stock"
Name="Arcutis BiotherapeuticsÂ Inc"
Description="Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California."
CIK="1787306"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2945 TOWNSGATE ROAD, SUITE 110, WESTLAKE VILLAGE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="550570000"
EBITDA="-315241984"
PERatio="None"
PEGRatio="None"
BookValue="1.306"
DividendPerShare="0"
DividendYield="0"
EPS="-5.7"
RevenuePerShareTTM="0.187"
ProfitMargin="0"
OperatingMarginTTM="-28.18"
ReturnOnAssetsTTM="-0.637"
ReturnOnEquityTTM="-2.398"
RevenueTTM="11237000"
GrossProfitTTM="2932000"
DilutedEPSTTM="-5.7"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="41.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1385.79"
PriceToBookRatio="3.742"
EVToRevenue="1017.85"
EVToEBITDA="-2.448"
Beta="0.601"
num_52WeekHigh="26.87"
num_52WeekLow="6.39"
num_50DayMovingAverage="9.27"
num_200DayMovingAverage="12.73"
SharesOutstanding="61654000"
DividendDate="None"
ExDividendDate="None"
symbol="ARQT"
open="8.94"
high="9.10"
low="8.34"
price="8.54"
volume="1131219.00"
latest_trading_day="2023-08-31"
previous_close="8.93"
change="-0.39"
change_percent="-4.3673%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="92"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="8"
Volume_recent_avg="1184707"
Change_recent_avg="-0.04"
Delta_recent_avg="0.74"
Variance_recent_avg="0.37"
Change_ratio_recent_avg="-0.49"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="8"
Aroon_momentum_negative="92"
image_negative_thumbnail_id_1="497"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0108.jpeg"
image_negative_thumbnail_id_2="110"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0066.jpeg"
image_neutral_thumbnail_id_1="545"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_neutral_thumbnail_id_2="589"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_positive_thumbnail_id_1="698"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0010.jpeg"
image_positive_thumbnail_id_2="645"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0063.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
